Artivion Inc - Asset Resilience Ratio

Latest as of September 2021: 0.07%

Artivion Inc (AORT) has an Asset Resilience Ratio of 0.07% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$538.00K
Cash + Short-term Investments

Total Assets

$818.65 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1999–2020)

This chart shows how Artivion Inc's Asset Resilience Ratio has changed over time. Check AORT strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Artivion Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AORT company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $538.00K 0.07%
Total Liquid Assets $538.00K 0.07%

Asset Resilience Insights

  • Limited Liquidity: Artivion Inc maintains only 0.07% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Artivion Inc Industry Peers by Asset Resilience Ratio

Compare Artivion Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
APT Medical Inc
SHG:688617
Medical Devices 8.63%
Medacta Group SA
SW:MOVE
Medical Devices 0.86%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
Medical Devices 49.23%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 34.47%

Annual Asset Resilience Ratio for Artivion Inc (1999–2020)

The table below shows the annual Asset Resilience Ratio data for Artivion Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2020-12-31 0.07% $546.00K $789.40 Million -0.02pp
2019-12-31 0.09% $528.00K $605.65 Million -0.04pp
2018-12-31 0.13% $747.00K $571.09 Million 0.00pp
2017-12-31 0.13% $776.00K $591.67 Million -0.09pp
2016-12-31 0.22% $699.00K $316.14 Million -0.24pp
2015-12-31 0.46% $830.00K $181.18 Million -2.76pp
2007-12-31 3.22% $2.99 Million $92.68 Million -1.74pp
2006-12-31 4.96% $3.96 Million $79.86 Million -1.50pp
2005-12-31 6.47% $4.97 Million $76.81 Million +1.07pp
2004-12-31 5.40% $3.96 Million $73.26 Million -1.63pp
2003-12-31 7.03% $5.27 Million $75.03 Million -6.68pp
2002-12-31 13.70% $14.58 Million $106.41 Million -6.78pp
2001-12-31 20.48% $26.48 Million $129.31 Million +1.52pp
2000-12-31 18.96% $21.23 Million $112.01 Million -7.00pp
1999-12-31 25.95% $24.40 Million $94.03 Million --
pp = percentage points

About Artivion Inc

NYSE:AORT USA Medical Devices
Market Cap
$1.23 Billion
Market Cap Rank
#8141 Global
#2410 in USA
Share Price
$25.37
Change (1 day)
+1.24%
52-Week Range
$20.10 - $47.63
All Time High
$47.63
About

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid… Read more